Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2976935 | Journal of Nuclear Cardiology | 2008 | 7 Pages |
Abstract
First-pass dynamic H215O PET for the assessment of forward SV is feasible, although values are progressively overestimated with increasing SV, particularly when the RV is used, and correlations with aorta velocity-encoded phase-contrast CMR are moderate. These findings are probably protocol-dependent and warrant further study before the use of first-pass dynamic H215O PET in clinical or research settings can be advocated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Paul MD, Mark PhD, Luuk J. MD, Rutger W. MD, Michiel MSc, Tjeerd MD, Jeroen J. MD, Jan W.A. MD, Hildo J. MD, Albert C. MD, Michaela MD, Frans C. MD, Adriaan A. PhD,